首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1746526

日本敗血症診斷市場報告（依診斷、產品、檢測方式、技術、病原體、最終用戶和地區）2025-2033

Japan Sepsis Diagnostics Market Report by Diagnosis, Product, Mode of Testing, Technology, Pathogen, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 122 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本敗血症診斷市場規模達2,410萬美元。展望未來， IMARC Group預計到2033年，該市場規模將達到4,850萬美元，2025-2033年期間的複合年成長率（CAGR）為7.4%。先進資料分析工具的日益普及，通常能夠整合來自不同平台的多項檢測結果，從而提供即時資料存取和精準的疾病診斷，是推動市場成長的主要動力。

敗血症是人體在抵抗細菌、病毒或真菌感染時所產生的反應，進而引發敗血症。在敗血症狀態下，免疫系統會釋放各種化學物質進入血液，引發全身性過度發炎和血栓形成。敗血症可導致多重器官衰竭、呼吸不規則、低血壓、神經功能障礙、心跳加速等。檢測敗血症的診斷方法主要包括分子診斷、免疫測定、微流體技術、生物標記、流式細胞儀及其他類似技術。這些診斷技術廣泛應用於各種醫療機構，包括醫院、病理實驗室、參考實驗室和學術研究機構等。

日本敗血症診斷市場趨勢：

在日本市場，敗血症診斷需求的激增可歸因於幾個關鍵因素。首先，可能導致敗血症的醫院內感染 (HAI) 顯著增加，尤其是在老年人、嬰兒和慢性病患者等弱勢群體中。這一趨勢是改善敗血症診斷工具需求的驅動力。其次，由抗生素抗藥性細菌（包括革蘭氏陽性菌和革蘭氏陰性菌）引起的傳染病病例不斷增加，這導致日本對敗血症診斷的需求增加。這些抗生素抗藥性菌株需要準確及時的診斷才能有效治療。此外，日本不斷擴張的醫療保健產業，加上先進資料分析工具的廣泛應用，在催化敗血症診斷市場的成長方面發揮著重要作用。這些工具能夠整合來自不同平台的不同測試結果，提供對關鍵資料的即時存取和精確的疾病診斷。此外，持續的技術進步促進了新型免疫學和分子生物標記的開發，從而促進了敗血症的早期檢測。預計在預測期內，對包括用於識別和管理慢性感染的創新血液培養方法在內的廣泛研發活動的投入，將有助於日本敗血症診斷市場的擴張。

日本敗血症診斷市場細分：

診斷見解：

自動診斷
常規診斷

產品洞察：

儀器
檢測試劑盒和試劑
血培養基
軟體

測試模式洞察：

實驗室檢查
即時檢驗

技術洞察：

分子診斷
免疫測定
生物標記
流式細胞儀
微流體
血液培養

病原體洞察：

細菌性敗血症
- 革蘭氏陽性細菌性敗血症
- 革蘭氏陰性菌性敗血症
病毒性敗血症
黴菌性敗血症
其他

最終用戶洞察：

診斷診所
醫院
研究實驗室

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本敗血症診斷市場迄今表現如何，未來幾年將如何表現？
COVID-19 對日本敗血症診斷市場有何影響？
根據診斷，日本敗血症診斷市場是如何分類的？
日本敗血症診斷市場依產品分類的狀況如何？
根據檢測方式，日本敗血症診斷市場是如何分類的？
日本敗血症診斷市場依技術分類的分佈如何？
日本敗血症診斷市場根據病原體是如何分類的？
根據最終用戶，日本敗血症診斷市場是如何分類的？
日本敗血症診斷市場的價值鏈分為哪些階段？
日本敗血症診斷的主要促進因素和挑戰是什麼？
日本敗血症診斷市場的結構是怎麼樣的？主要參與者是誰？
日本敗血症診斷市場的競爭程度如何？

本報告回答的關鍵問題：

日本敗血症診斷市場迄今表現如何，未來幾年將如何表現？
COVID-19 對日本敗血症診斷市場有何影響？
根據診斷，日本敗血症診斷市場是如何分類的？
日本敗血症診斷市場依產品分類的狀況如何？
根據檢測方式，日本敗血症診斷市場是如何分類的？
日本敗血症診斷市場依技術分類的分佈如何？
日本敗血症診斷市場根據病原體是如何分類的？
根據最終用戶，日本敗血症診斷市場是如何分類的？
日本敗血症診斷市場的價值鏈分為哪些階段？
日本敗血症診斷的主要促進因素和挑戰是什麼？
日本敗血症診斷市場的結構是怎麼樣的？主要參與者是誰？
日本敗血症診斷市場的競爭程度如何？

Japan sepsis diagnostics market size reached USD 24.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 48.5 Million by 2033, exhibiting a growth rate (CAGR) of 7.4% during 2025-2033. The increasing adoption of advanced data analytics tools that generally enable the integration of multiple test results from different platforms to offer real-time data access and accurate disease diagnosis is primarily driving the market growth.

Sepsis is a medical condition that arises as a response of the body when it attempts to combat infections caused by the presence of bacteria, viruses, or fungi. In this state, the immune system releases various chemicals into the bloodstream, setting off excessive inflammation and the formation of blood clots throughout the body. Sepsis can lead to the failure of multiple organs, irregular breathing, low blood pressure, neurological dysfunction, an elevated heart rate, and more. The diagnostic methods for detecting sepsis primarily encompass molecular diagnosis, immunoassays, microfluidics, biomarkers, flow cytometry, and similar technologies. These diagnostic techniques see widespread use in various healthcare settings, including hospitals, pathology laboratories, reference laboratories, and academic research institutions, among others.

Japan Sepsis Diagnostics Market Trends:

In the Japanese market, the surge in demand for sepsis diagnostics can be attributed to several key factors. Firstly, there is a noticeable increase in hospital-acquired infections (HAIs) that can lead to sepsis, particularly among vulnerable demographic groups such as the elderly, infants, and patients with chronic ailments. This trend is a driving force behind the need for improved sepsis diagnostic tools. Secondly, the growing instances of infectious diseases caused by antibiotic-resistant bacteria, including both gram-positive bacteria and gram-negative bacilli, are contributing to the heightened demand for sepsis diagnostics in Japan. These antibiotic-resistant strains require accurate and timely diagnosis for effective treatment. Furthermore, Japan's expanding healthcare sector, coupled with the widespread adoption of advanced data analytics tools, is playing a significant role in catalyzing the growth of the sepsis diagnostics market. These tools enable the integration of diverse test results from various platforms, offering real-time access to critical data and precise disease diagnosis. Additionally, continuous technological advancements have led to the development of new immunological and molecular biomarkers, facilitating early sepsis detection. Investment in extensive research and development activities, including innovative blood culture methods for identifying and managing chronic infections, is expected to contribute to the expansion of the sepsis diagnostics market in Japan over the forecasted period.

Japan Sepsis Diagnostics Market Segmentation:

Diagnosis Insights:

Automated Diagnostics
Conventional Diagnostics

Product Insights:

Instruments
Assay Kits and Reagents
Blood Culture Media
Software

Mode of Testing Insights:

Laboratory Tests
Point-of-Care Tests

Technology Insights:

Molecular Diagnostics
Immunoassays
Biomarkers
Flow Cytometry
Microfluidics
Blood Culture

Pathogen Insights:

Bacterial Sepsis
- Gram-Positive Bacterial Sepsis
- Gram-Negative Bacterial Sepsis
Viral Sepsis
Fungal Sepsis
Others

End User Insights:

Diagnostic Clinics
Hospitals
Research Laboratories

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan sepsis diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan sepsis diagnostics market?
What is the breakup of the Japan sepsis diagnostics market on the basis of diagnosis?
What is the breakup of the Japan sepsis diagnostics market on the basis of product?
What is the breakup of the Japan sepsis diagnostics market on the basis of mode of testing?
What is the breakup of the Japan sepsis diagnostics market on the basis of technology?
What is the breakup of the Japan sepsis diagnostics market on the basis of pathogen?
What is the breakup of the Japan sepsis diagnostics market on the basis of end User?
What are the various stages in the value chain of the Japan sepsis diagnostics market?
What are the key driving factors and challenges in the Japan sepsis diagnostics?
What is the structure of the Japan sepsis diagnostics market and who are the key players?
What is the degree of competition in the Japan sepsis diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Sepsis Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Sepsis Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Sepsis Diagnostics Market - Breakup by Diagnosis

6.1 Automated Diagnostics
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Conventional Diagnostics
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Sepsis Diagnostics Market - Breakup by Product

7.1 Instruments
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Assay Kits and Reagents
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Blood Culture Media
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Software
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)

8 Japan Sepsis Diagnostics Market - Breakup by Mode of Testing

8.1 Laboratory Tests
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Point-of-Care Tests
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)

9 Japan Sepsis Diagnostics Market - Breakup by Technology

9.1 Molecular Diagnostics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Immunoassays
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Biomarkers
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Flow Cytometry
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
9.5 Microfluidics
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2019-2024)
- 9.5.3 Market Forecast (2025-2033)
9.6 Blood Culture
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2019-2024)
- 9.6.3 Market Forecast (2025-2033)

10 Japan Sepsis Diagnostics Market - Breakup by Pathogen

10.1 Bacterial Sepsis
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Segmentation
  - 10.1.3.1 Gram-Positive Bacterial Sepsis
  - 10.1.3.2 Gram-Negative Bacterial Sepsis
- 10.1.4 Market Forecast (2025-2033)
10.2 Viral Sepsis
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Fungal Sepsis
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
10.4 Others
- 10.4.1 Historical and Current Market Trends (2019-2024)
- 10.4.2 Market Forecast (2025-2033)

11 Japan Sepsis Diagnostics Market - Breakup by End User

11.1 Diagnostic Clinics
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2019-2024)
- 11.1.3 Market Forecast (2025-2033)
11.2 Hospitals
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2019-2024)
- 11.2.3 Market Forecast (2025-2033)
11.3 Research Laboratories
- 11.3.1 Overview
- 11.3.2 Historical and Current Market Trends (2019-2024)
- 11.3.3 Market Forecast (2025-2033)

12 Japan Sepsis Diagnostics Market - Competitive Landscape

12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant

13 Profiles of Key Players

13.1 Company A
- 13.1.1 Business Overview
- 13.1.2 Services Offered
- 13.1.3 Business Strategies
- 13.1.4 SWOT Analysis
- 13.1.5 Major News and Events
13.2 Company B
- 13.2.1 Business Overview
- 13.2.2 Services Offered
- 13.2.3 Business Strategies
- 13.2.4 SWOT Analysis
- 13.2.5 Major News and Events
13.3 Company C
- 13.3.1 Business Overview
- 13.3.2 Services Offered
- 13.3.3 Business Strategies
- 13.3.4 SWOT Analysis
- 13.3.5 Major News and Events
13.4 Company D
- 13.4.1 Business Overview
- 13.4.2 Services Offered
- 13.4.3 Business Strategies
- 13.4.4 SWOT Analysis
- 13.4.5 Major News and Events
13.5 Company E
- 13.5.1 Business Overview
- 13.5.2 Services Offered
- 13.5.3 Business Strategies
- 13.5.4 SWOT Analysis
- 13.5.5 Major News and Events

14 Japan Sepsis Diagnostics Market - Industry Analysis

14.1 Drivers, Restraints, and Opportunities
- 14.1.1 Overview
- 14.1.2 Drivers
- 14.1.3 Restraints
- 14.1.4 Opportunities
14.2 Porters Five Forces Analysis
- 14.2.1 Overview
- 14.2.2 Bargaining Power of Buyers
- 14.2.3 Bargaining Power of Suppliers
- 14.2.4 Degree of Competition
- 14.2.5 Threat of New Entrants
- 14.2.6 Threat of Substitutes
14.3 Value Chain Analysis